OSI-027 (Compound)

Synonyms:OSI-027, 936890-98-1, OSI027, OSI 027, 25MKH1SZ0M, AEVI-006, CERC-006, ASP-7486, 936890-98-1 (free acid), 4-[(5Z)-4-amino-5-(7-methoxyindol-2-ylidene)-1H-imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylic acid, (1r,4r)-4-(4-Amino-5-(7-methoxy-1H-indol-2-yl)imidazo-[5,1-f][1,2,4]triazin-7-yl)cyclohexanecarboxylic acid, Cyclohexanecarboxylic acid, 4-(4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo(5,1-f)(1,2,4)triazin-7-yl)-, trans-, trans-4-[4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]-cyclohexanecarboxylic acid, TRANS-4-[4-AMINO-5-(7-METHOXY-1H-INDOL-2-YL)IMIDAZO[5,1-F][1,2,4]TRIAZIN-7-YL]CYCLOHEXANECARBOXYLIC ACID, UNII-25MKH1SZ0M, Cyclohexanecarboxylic acid, 4-[4-amino-5-(7-methoxy-1h-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]-, trans-, trans-4-(4-Amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl)cyclohexanecarboxylic acid, 1187559-66-5, CERC006, MLS006011006, SCHEMBL976795, SCHEMBL976796, CERC 006, CHEMBL2132692, CHEMBL3120215, OSI-027 [WHO-DD], SCHEMBL20482333, SCHEMBL22594988, SCHEMBL22787096, CHEBI:91363, ASP4786, ASP7486, EX-A143, BDBM185151, DTXSID901025951, HMS3656H05, HMS3748I11, ASP 7486, BCP02613, NSC800810, s2624, AKOS030238938, AKOS037643584, AM81260, BCP9001034, CCG-268721, CS-0257, DB12387, NSC-800810, SB19259, NCGC00250395-01, NCGC00386179-01, NCGC00386179-04, NCGC00387858-03, (+/-)-Cyclohexanecarboxylic acid, 4-(4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo(5,1-f)(1,2,4)triazin-7-yl)-, trans-, AC-31517, AS-17003, HY-10423, LS-14875, SMR004702804, DB-079654, SW220246-1, F17371, J-523839, BRD-K94294671-003-01-3, Q27163231, Q27253978, (1r,4r)-4-(4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl)cyclohexanecarboxylic acid, 4-[4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylic acid, 4-[4-amino-5-(7-methoxy-2-indolylidene)-1H-imidazo[5,1-f][1,2,4]triazin-7-yl]-1-cyclohexanecarboxylic acid, trans-4-[4-amino-5-(7-methoxy-1H-indol-2-yl)-imidazo[5,1-f][1,2,4]triazin-7-yl]-cyclohexanecarboxylic acid

Pubchem:PUBCHEM:135398516

Id:b880892a-3e60-5534-8309-4828837f1a17

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View OSI-027's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for OSI-027.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with OSI-027.

Results found

Linked to

	Label	Description
	BRD-K94294671-003-01-3 Substance (Entity type)	A Substance
	osi-027 (b16ffc97-0bf8-46e7-b766-9b9539554726) Collection (Entity type)	Metadatata for osi-027
	osi-027 (499b6ee9-e8fc-4132-9dac-f222bb28c62b) Collection (Entity type)	Metadatata for osi-027
	OSI-027 negatively regulates SCD Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	OSI-027 positively regulates TM4SF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	OSI-027 positively regulates ITGA6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	OSI-027 positively regulates IMPDH2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	OSI-027 in similarity relationship with dactolisib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	OSI-027 positively regulates TFPI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	OSI-027 positively regulates IFITM1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS